Bone marrow transplantation for acute monocytic leukemia following the treatment of Hodgkin's disease.

Abstract

A 32-year-old woman developed acute monocytic leukemia within a year of treatment for Hodgkin's disease with chemotherapy and radiation. Residual leukemia was present in the bone marrow after two induction courses of high-dose Ara-C. She received a bone marrow transplant from an HLA- and DR-identical sister and remains in complete remission more than 2 years after transplantation. Only one other instance of a remission greater than 2 years after transplantation for secondary acute leukemia could be found in the literature. Although bone marrow transplantation may be carried out successfully in these patients, it is possible that they may be more vulnerable to transplant-related complications because of their previous exposure to chemotherapy and radiation. Only further study can clarify this matter and determine the best time for the procedure and which regimen should be used.

• Authors: J A Russell, B Houwen, B A Ruether, K H Shin, A R Jones, T Bowen, M C Poon
• Journal: Medical and pediatric oncology (Med Pediatr Oncol) Vol. 14 Issue 6 Pg. 319-22 ( 1986) ISSN: 0098-1532 [Print] United States
• PMID: 3537654 (Publication Type: Case Reports, Journal Article)

Chemical References

• Cytarabine

Topics

• Adult
• Antineoplastic Combined Chemotherapy Protocols (adverse effects)
• Bone Marrow (pathology)
• Bone Marrow Transplantation
• Combined Modality Therapy
• Cytarabine (administration & dosage)
• Female
• Follow-Up Studies
• Hodgkin Disease (complications, therapy)
• Humans
• Leukemia, Monocytic, Acute (etiology, pathology, therapy)
• Radiotherapy (adverse effects)